Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial

Esper G. Kallas, Alexander Roberto Precioso, Ricardo Palacios, Beatriz Thomé, Patrícia Emília Braga, Tazio Vanni, Lúcia M.A. Campos, Lilian Ferrari, Gabriella Mondini, Maria da Graça Salomão, Anderson da Silva, Heloisa M. Espinola, Joane do Prado Santos, Cecilia L.S. Santos, Maria do Carmo S.T. Timenetsky, João Luiz Miraglia, Neuza M.F. Gallina, Daniela Weiskopf, Alessandro Sette, Raphaella GoulartRafael Tavares Salles, Alvino Maestri, Adriana Maluf Elias Sallum, Sylvia Costa Lima Farhat, Neusa K. Sakita, Juliana C.O.A. Ferreira, Cassia G.T. Silveira, Priscilla R. Costa, Isaias Raw, Stephen S. Whitehead, Anna P. Durbin, Jorge Kalil

Research output: Contribution to journal › Article › peer-review

Fingerprint Dive into the research topics of 'Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences